Jackson Square Partners LLC Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jackson Square Partners LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 10.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 25,132 shares of the medical equipment provider's stock after selling 3,013 shares during the period. Jackson Square Partners LLC's holdings in Intuitive Surgical were worth $8,479,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. OFI Invest Asset Management acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $25,000. Baystate Wealth Management LLC boosted its holdings in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider's stock worth $25,000 after buying an additional 45 shares during the last quarter. MCF Advisors LLC grew its position in shares of Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider's stock worth $26,000 after buying an additional 40 shares during the period. Headinvest LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $28,000. Finally, Stone House Investment Management LLC raised its position in shares of Intuitive Surgical by 100.0% in the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 50 shares during the period. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an "overweight" rating in a report on Friday, January 19th. Truist Financial boosted their target price on Intuitive Surgical from $390.00 to $435.00 and gave the company a "buy" rating in a research note on Wednesday, January 24th. Robert W. Baird dropped their price target on Intuitive Surgical from $440.00 to $436.00 and set an "outperform" rating on the stock in a research report on Friday, April 19th. StockNews.com downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a report on Thursday, February 29th. Finally, Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a "buy" rating in a report on Monday, April 8th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $396.17.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $2.39 during trading on Friday, reaching $398.82. 720,293 shares of the company's stock were exchanged, compared to its average volume of 1,263,174. The business has a 50 day moving average price of $384.97 and a 200-day moving average price of $358.29. The stock has a market capitalization of $141.46 billion, a P/E ratio of 71.99, a PEG ratio of 5.12 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts' consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period in the previous year, the firm earned $1.00 EPS. The firm's revenue was up 11.5% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 175 shares of the stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $387.22, for a total transaction of $67,763.50. Following the transaction, the senior vice president now owns 533 shares in the company, valued at $206,388.26. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, SVP Mark Brosius sold 175 shares of the firm's stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $387.22, for a total transaction of $67,763.50. Following the transaction, the senior vice president now directly owns 533 shares of the company's stock, valued at $206,388.26. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 20,296 shares of the business's stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the completion of the sale, the executive vice president now directly owns 5,507 shares of the company's stock, valued at approximately $2,168,656.60. The disclosure for this sale can be found here. In the last 90 days, insiders sold 148,290 shares of company stock worth $57,207,154. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.